Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.
AUTOR(ES)
Ross, A H
RESUMO
The nerve growth factor (NGF) receptor was characterized by using a new series of anti-receptor monoclonal antibodies (MAbs). These MAbs (i) showed significantly greater reactivity with a melanoma cell line expressing higher levels of NGF receptor, (ii) inhibited the binding of 125I-labeled NGF to its receptor, and (iii) immunoprecipitated both metabolically labeled and 125I-labeled NGF affinity-labeled receptor. These experiments defined the receptor as a 75-kDa cell-surface protein. The NGF receptor was visualized by immunoperoxidase staining in tissue sections of human nevi, melanomas, neurofibromas, a pheochromocytoma, and peripheral nerves. Uniform staining of the cytoplasm suggests that, in addition to cell-surface NGF receptors, there is a population of intracellular receptors.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=391994Documentos Relacionados
- Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.
- Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.
- Specific modulation of sodium channels in mammalian nerve by monoclonal antibodies.
- Topological analysis of the Escherichia coli ferrichrome-iron receptor by using monoclonal antibodies.
- Monoclonal antibodies against beta nerve growth factor and their effects on receptor binding and biological activity.
